News & Perspectives
Part I: Biotech Deals — Creating Optimal Licensing and Partnering Arrangements
Please join Arnold & Porter for Part I of our in-person series designed for legal and business leaders at biotechnology companies focused on optimizing their licensing and partnering.
DOJ’s FCA Enforcement Priorities — Insights From the Deputy Assistant Attorney General
Take a closer look at DOJ’s evolving FCA enforcement priorities to understand where scrutiny is intensifying—and proactively adjust your compliance approach to reduce risk and stay ahead of enforcement trends.
Virtual and Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during February and early March 2026 from the United States, United Kingdom, and European Union.
U.S. Health and Human Services Tries Again To Improve Availability of Innovative Devices in Medicare
Act now to understand how HHS’ latest proposal could reshape Medicare coverage pathways for innovative devices—and position your organization to capitalize on emerging opportunities while navigating evolving regulatory requirements.